HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|33|3886-3894

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.33, 2009-11, pp. : 3886-3894

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIF Prolyl 4-Hydroxylases and their Potential as Drug Targets

By  

Current Pharmaceutical Design, Vol. 15, Iss. 33, 2009-11 ,pp. : 3878-3885

Bentham Science Publishers

Access to resources Recommend Favorite

HIF prolyl hydroxylase inhibitors for anemia

By Muchnik Eugene   Kaplan Joshua  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 645-656

Informa Healthcare

Access to resources Recommend Favorite

A Combination of 3D-QSAR Modeling and Molecular Docking Approach for the Discovery of Potential HIF Prolyl Hydroxylase Inhibitors

By  

Medicinal Chemistry, Vol. 9, Iss. 3, 2013-01 ,pp. : 360-370

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine Receptor Interacting Proteins: Targeting Neuronal Calcium Sensor-1/D2 Dopamine Receptor Interaction for Antipsychotic Drug Development

By  

Current Drug Targets, Vol. 13, Iss. 1, 2012-01 ,pp. : 72-79

Bentham Science Publishers

Access to resources Recommend Favorite

Postmitotic differentiation of rat lung fibroblasts: induction by bleomycin and effect on prolyl 4-hydroxylase

By Koslowski Roland   Morgner Jacqueline   Seidel Dagmar   Knoch Klaus-Peter   Kasper Michael  

Experimental and Toxicologic Pathology, Vol. 55, Iss. 6, 2004-07 ,pp. : 481-487

Urban & Fischer

Access to resources Recommend Favorite